AMA-Manatt 2024: Improving Access to Care Pregnant Parenting People with SUD

The American Medical Association (AMA) and Manatt have developed recommendations for policymakers to improve access to care for pregnant and postpartum people with opioid use disorder, focusing several strategies on justice-involved individuals.

AMA-Manatt Profiles in Leadership 2022

“The fight to end the nation’s overdose epidemic and restore compassionate care: Profiles in leadership.” Read more how a select group of physicians, policymakers and patient advocates exemplify proven policies and actions that help save lives and improve outcomes for people with substance use disorders, patients with pain, and those who need harm reduction services.

2022 AMA Overdose Epidemic Report

Opioid prescribing continues downward trend while overdose and death related to illicitly manufactured fentanyl, methamphetamine and cocaine increase.

The AMA and Manatt Health 2022 State Toolkit

The AMA and Manatt Health 2022 State Toolkit identifies more than 400 state laws, regulations, policy guidance and other select national actions being implemented to help end the nation's drug overdose epidemic. We encourage all states to use this resource as a go-to guide to increase access to evidence-based treatment and save lives from overdose.

AMA Opioid Task Force 2020 Progress Report

Sharp reductions in prescription opioid supply, continued increases in PDMP use, but staggering increase in fatalities involving illicit opioids, methamphetamine, heroin and cocaine were demonstrated in 2019.

AMA Opioid Task Force 2019 Progress Report

The 2019 progress report highlights physician action and the immediate need for policymakers to focus on removing barriers to evidence-based treatment.

Be part of the solution.

Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.